---
title: "PDS Biotechnology Q1 2026 earnings preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286130832.md"
description: "PDS Biotechnology (PDSB) will announce its Q1 earnings on May 13th, before market open. The consensus EPS estimate is -$0.14, reflecting a 33.3% year-over-year increase, with revenue estimated at $0M. In the past three months, there has been one upward revision in EPS estimates and no downward revisions."
datetime: "2026-05-12T16:11:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286130832.md)
  - [en](https://longbridge.com/en/news/286130832.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286130832.md)
---

# PDS Biotechnology Q1 2026 earnings preview

PDS Biotechnology (PDSB) is scheduled to announce Q1 earnings results on Wednesday, May 13th, before market open. The consensus EPS Estimate is -$0.14 (+33.3% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. More on PDS Biotechnology PDS Biotechnology Corporation (P...

### Related Stocks

- [PDSB.US](https://longbridge.com/en/quote/PDSB.US.md)

## Related News & Research

- [PDS Biotechnology updates corporate presentation highlighting Phase 3 VERSATILE-003, 39.3m mOS and upcoming catalysts](https://longbridge.com/en/news/284050202.md)
- [China Natural Resources GAAP EPS of -$0.14](https://longbridge.com/en/news/286620443.md)
- [Calidi Biotherapeutics GAAP EPS of -$0.43](https://longbridge.com/en/news/286474175.md)
- [Aptera Motors Non-GAAP EPS of -$0.19](https://longbridge.com/en/news/286578231.md)
- [Range Impact GAAP EPS of -$0.02, revenue of $0.92M](https://longbridge.com/en/news/286725496.md)